Drugdu.com : Global Leading Pharmaceuticals & Medical Devices B2B Online...

评论

发表评论

此博客中的热门博文

The future of lung function tests for COPD

With the global increase of  lung diseases  such as asthma, severe bronchitis and emphysema,  lung function tests  are becoming a bigger concern for many people. Spirometry  (measuring lung function) is the most well know  pulmonary function test  and vital to diagnose  COPD . Some of the diseases which can be detected are: 1. Chronic obstructive pulmonary disease (COPD) – main term used to describe lung diseases such as asthma, emphysema, chronic bronchitis etc. 2. Asthma – common and long-term lung disease characterised by coughing, shortness of breath or wheezing. 3. Chronic bronchitis – bronchial tubes become inflamed and produce an excessive amount of mucus. 4. Emphysema – long-term progressive disease where alveoli in the lungs become inflamed causing shortness of breath. 5. Cystic fibrosis – genetic lung disease characterised by frequent lung infections and coughing up mucus as a result of this. 6. Pulmonary fibrosis - inte...
阅读全文

Press Conference for Ddu Credit Verification Launch

According to official Ddu news, the leading global pharmaceutical and medical device B2B online platform and SGS-CSTC (Standards Technical Services Co., Ltd.) will be calling a press conference in Shenzhen, China, on August 18, 2017 to launch their strategic partnership on credit verification and kick off the Ddu Credit Verification Service officially. In recent years, the cross-border medical trade in China has seen rapid development, however due to certain factors such as lack of integrity, time lags and remote regions, it has been difficult for buyers and suppliers to determine the quality of the trade which could lead to contract fraud, counterfeit and inferior goods as well as payment delinquencies and false transaction. To tackle these problems, a signing ceremony for strategic cooperation on credit verification will be held by Ddu and SGS-CSTC to officially launch the project. Yuan Shimin, CEO of Ddu, together with high priority members across the country, will gather to ...
阅读全文

China to adjust registration management for drugs and medical devices

To promote the adjustment of industrial structure and technological innovation in the drug and  medical device products  sector, the Communist Party of China’s Central Committee and the State Council jointly released a guideline on the reform of the review and approval system, which came into effect on October 8, 2017. The guideline lays out several primary objectives. These include overhauling the management of clinical trials, accelerating the drug and medical device approval process, promoting drug innovation and the development of generic drugs, enhancing the administration of drug and medical devices throughout the product life cycles, and improving technical review infrastructure for greater transparency and oversight. Notably, the guideline stipulates that qualified overseas clinical trial data can now be used in the drug andmedical device products registration and approval process. In the face of a grave threat to public health, drug and medical device registratio...
阅读全文